Pfizer already working on Covid vaccine targeting Omicron: CEO
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Saturday
August 20, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
SATURDAY, AUGUST 20, 2022
Pfizer already working on Covid vaccine targeting Omicron: CEO

Coronavirus chronicle

Reuters
30 November, 2021, 02:10 pm
Last modified: 30 November, 2021, 02:17 pm

Related News

  • Apple sets Sept 5 deadline for employees to return to office
  • Australia's PM says predecessor 'undermined democracy' with secret roles
  • Australia's PM says former PM Morrison took on secret ministerial roles during Covid
  • China’s economic recovery tested as Covid outbreaks persist
  • Nepal battles 'Twindemic' as swine flu wreaks havoc amid rising Covid cases

Pfizer already working on Covid vaccine targeting Omicron: CEO

Johnson & Johnson also said Monday that it is "pursuing an Omicron- specific variant vaccine and will progress it as needed."

Reuters
30 November, 2021, 02:10 pm
Last modified: 30 November, 2021, 02:17 pm
Syringes with the Pfizer-BioNTech vaccines to be administered against the coronavirus disease (COVID-19) lie on a tray during a program without an appointment in Sant Vicenc de Casteller, north of Barcelona, Spain, July 6, 2021. REUTERS/ Albert Gea
Syringes with the Pfizer-BioNTech vaccines to be administered against the coronavirus disease (COVID-19) lie on a tray during a program without an appointment in Sant Vicenc de Casteller, north of Barcelona, Spain, July 6, 2021. REUTERS/ Albert Gea

Pfizer has already started working on a version of its Covid-19 vaccine specifically targeting the new Omicron variant in case the current inoculation is not effective against the latest strain, the US drugmaker's CEO Albert Bourla said Monday.

Bourla told CNBC that his company on Friday began testing the current vaccine against the Omicron variant, which was first reported in South Africa and has reignited fears of a global wave of Covid-19 infections.

"I don't think the result will be the vaccines don't protect," Bourla said.

But the testing could show that existing shots "protect less," which would mean "that we need to create a new vaccine," Bourla said.

"Friday we made our first DNA template, which is the first possible inflection of the development process of a new vaccine," he said.

Johnson & Johnson also said Monday that it is "pursuing an Omicron- specific variant vaccine and will progress it as needed."

On Friday, Moderna, another leading Covid-19 vaccine maker, said it was developing a booster shot against the new variant.

Bourla likened the situation to the scenario earlier this year when Pfizer and its German partner BioNTech developed a vaccine in 95 days when there were concerns the previous formula would not work against Delta, though that version ultimately was not used.

The current vaccine is "very effective" against Delta, the executive said, adding that the companies expect to be able to produce four billion vaccine doses in 2022.

On Monday, the World Health Organization warned the new Covid-19 Omicron variant poses a "very high" risk globally.

Bourla said he was also "very confident" that Pfizer's recently unveiled antiviral pill would work as a treatment for infections caused by the mutations, including Omicron.

Among newly-infected, high risk patients treated within three days of the onset of symptoms, Pfizer's pill has been shown to cut hospitalization or death by nearly 90 percent.

Top News / World+Biz

Pfizer / omicron / Covid

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Stories beneath the trade data
    Stories beneath the trade data
  • Photo: Collected
    India also will be ashamed of FM Momen’s statement: Quader
  • Logo of BNP
    BNP slams Momen for 'asking India to keep PM Hasina's govt in power'

MOST VIEWED

  • N Korea's Kim praises military medics for frontline Covid fight in capital
    N Korea's Kim praises military medics for frontline Covid fight in capital
  • People walk at a subway station, following the outbreak of the coronavirus disease (Covid-19), in Shanghai, China May 11, 2021. REUTERS/Aly Song
    Two Covid scares cause mayhem in Shanghai
  • File Photo: A woman holds a small bottle labeled with a "Vaccine Covid-19" sticker and a medical syringe in this illustration taken April 10, 2020. Reuters/Dado Ruvic/Illustration
    Variant-adapted Covid vaccine wins first approval in Britain
  • Southern hemisphere to get first mRNA vaccine facility
    Southern hemisphere to get first mRNA vaccine facility
  • North Korea's leader Kim Jong Un greets health workers and scientists struggling with the coronavirus disease (Covid-19) pandemic during a photo session in Pyongyang, North Korea, in this undated photo released on August 10, 2022 by North Korea's Korean Central News Agency (KCNA). KCNA via REUTERS
    North Korea lifts mask mandate, distancing rules after declaring Covid victory
  • A motorist passes by a mural of frontline workers against coronavirus at RK Puram in New Delhi on July 25. Delhi’s Covid-19 recoveries have outstripped new cases on almost all days this month barring a few exceptions, after ramped-up containment and testing efforts over the past month or so. (Sanchit Khanna / HT Photo)
    Delhi to enforce mask mandate again after spurt in Covid cases

Related News

  • Apple sets Sept 5 deadline for employees to return to office
  • Australia's PM says predecessor 'undermined democracy' with secret roles
  • Australia's PM says former PM Morrison took on secret ministerial roles during Covid
  • China’s economic recovery tested as Covid outbreaks persist
  • Nepal battles 'Twindemic' as swine flu wreaks havoc amid rising Covid cases

Features

Illustration: TBS

China-Bangladesh currency clearance agreement can increase trade by 'an unimaginable scale': Li Jiming, Ambassador of China

12h | Interviews
Postcrossing (which connects people through its website) is a system built for postcard enthusiasts, where anyone can sign up and create an account for free. Photo: Noor A Alam

Postcrossers: Reviving a lost art with strangers and postcards

11h | Panorama
We will be facing massive, recurring challenges in the coming years no matter what. Photo: Reuters

Holes in the recession story

1d | Panorama
Illustration: Bloomberg

What nonmonogamy can teach moonlighters and job jugglers

1d | Pursuit

More Videos from TBS

Amazing folding smartphone

Amazing folding smartphone

3h | Videos
How Russia gets advantage for geographical location?

How Russia gets advantage for geographical location?

5h | Videos
Is textbooks enough for students?

Is textbooks enough for students?

5h | Videos
134-year-old traditional sandwich of New York

134-year-old traditional sandwich of New York

10h | Videos

Most Read

1
From left Afzal Karim, Murshedul Kabir and Mohammad Jahangir
Banking

Sonali, Agrani and Rupali banks get new MDs

2
Russia now offers Bangladesh finished oil
Energy

Russia now offers Bangladesh finished oil

3
Photo: TBS
Bangladesh

5 crushed to death as BRT girder falls on car in Uttara

4
Photo: Collected
Economy

Bangladesh is not in a crisis situation: IMF

5
Dollar price drops by Tk8 in kerb market
Economy

Dollar price drops by Tk8 in kerb market

6
Eight more banks make unusual gains from forex dealings
Banking

Eight more banks make unusual gains from forex dealings

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net